Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 AUD | -3.57% | 0.00% | +42.11% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Howie McKibbon
CEO | Chief Executive Officer | - | 30/04/19 |
Vincent Ippolito
CHM | Chairman | 65 | 19/05/19 |
Chief Tech/Sci/R&D Officer | 68 | 28/02/21 | |
Henry Bosch
BRD | Director/Board Member | - | 30/06/16 |
Jack Hoblitzell
PRN | Corporate Officer/Principal | - | 23/09/21 |
Anthony Robinson
PRN | Corporate Officer/Principal | - | 28/02/21 |
Susan Park
SEC | Corporate Secretary | 49 | 16/04/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stewart Washer
BRD | Director/Board Member | 54 | 20/02/19 |
Henry Bosch
BRD | Director/Board Member | - | 30/06/16 |
Vincent Ippolito
CHM | Chairman | 65 | 19/05/19 |
Matthew Callahan
FOU | Founder | 51 | 30/06/16 |
Daniel Sharp
BRD | Director/Board Member | - | 21/03/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,547,144,642 | 1,319,431,449 ( 85.28 %) | 0 | 85.28 % |
Company contact information
Botanix Pharmaceuticals Ltd.
661 Newcastle Street Unit D2
6007, Leederville
+
http://www.botanixpharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+42.11% | 291M | |
+9.33% | 72.5B | |
+13.69% | 9.11B | |
-11.75% | 5.07B | |
+59.61% | 5.01B | |
+2.62% | 3.85B | |
-17.54% | 2.46B | |
+21.27% | 2.44B | |
+25.13% | 2.27B | |
-27.82% | 2.26B |
- Stock Market
- Equities
- BOT Stock
- Company Botanix Pharmaceuticals Limited